Moxifloxacin Population Pharmacokinetics and Model-Based Comparison of Efficacy between Moxifloxacin and Ofloxacin in African Patients
- 期刊名称Antimicrobial Agents and Chemotherapy
- 作者Zvada, S. P.; Denti, P.; Sirgel, F. A.; Chigutsa, E.; Hatherill, M.; Charalambous, S.; Mungofa, S.; Wiesner, L.; Simonsson, U. S. H.; Jindani, A.; Harrison, T.; McIlleron, H. M.
- 卷第58卷
- 期第1期
- 印刷ISSN0066-4804
- 电子ISSN1098-6596
- 文件大小645.63KB
- 发表时间2014-01-01
- DOI10.1128/aac.01478-13
- 页码503-510
Bortezomib plus rituximab versus rituximab alone in patients with relapsed, rituximab-naive or rituximab-sensitive, follicular lymphoma: a randomised phase 3 trialBertrand Coiffier; Evgenii A Osmanov; Xiaonan Hong; Adriana Scheliga; Jiri Mayer; Fritz Offner; Simon Rule; Adriana Teixeira; Jan Walewski; Sven de Vos; Michael Crump; Ofer Shpilberg; Dixie-Lee Esseltine; Eugene Zhu; Christopher Enny; Panteli Theocharous; Helgi van de Velde; Yusri A Elsayed; Pier Luigi Zinzani · 2011
061. Rituximab-Associated Neutropaenia: Safety of Retreatment Rituximab TherapyRheumatology · 2015
Bortezomib plus rituximab versus rituximab in patients with high-risk, relapsed, rituximab-naïve or rituximab-sensitive follicular lymphoma: subgroup analysis of a randomized phase 3 trialPier Luigi Zinzani, Nuriet K Khuageva, Huaqing Wang, Bernardo Garicochea, Jan Walewski, Achiel Van Hoof, Pierre Soubeyran, Dolores Caballero, Rena Buckstein, Dixie-Lee Esseltine, Panteli Theocharous, Christopher Enny, Eugene Zhu, Yusri A Elsayed, Bertrand Coiffier · 2012
The Cost-Effectiveness of Bendamustine-Rituximab Versus Fludarabine-Rituximab for Patients with Indolent Non-Hodgkin’s Lymphoma (INHL) Who Have Progressed Following Treatment with Rituximab or a Rituximab-Containing Regimen in ColombiaBertwistle, D.; Munakata, J.; Wehler, E; Leyva, V.; Ariza, J.G.; Zambrano, C.; Gonzalez, L. · Value in Health · 2013
The Cost-Effectiveness of Bendamustine-Rituximab Versus Fludarabine-Rituximab for Patients with Indolent Non-Hodgkin’s Lymphoma (INHL) Who Have Progressed Following Treatment with Rituximab or a Rituximab-Containing Regimen in MexicoBertwistle, D.; Munakata, J.; Wehler, E.; Leyva, V.; Valencia, A.; Hernandez, A.; de la Torre, L.; Gonzalez, L. · Value in Health · 2013
Is Rituximab Infusion Getting Easier? (Is it Safe to Give Rituximab Faster?)S. Vieira; D. Monroe · 2011
Maintenance Rituximab is associated with improved clinical outcome in rituximab naïve patients with Waldenstrom Macroglobulinaemia who respond to a rituximab-containing regimenSteven P. Treon; Christina Hanzis; Robert J. Manning; Leukothea Ioakimidis; Christopher J. Patterson; Zachary R. Hunter; Patricia Sheehy; Barry Turnbull · 2011
Are skin tests to Rituximab a risk marker for Rituximab hypersensivity?Galvis, Jonnathan Acevedo; Solano, Emilio; Zepeda, Cristiana Solorzano; De La Hoz, Belen · Journal of Allergy and Clinical Immunology · 2020
Biperiden/trihexyphenidylReactions Weekly · 1995
NitrendipineReactions Weekly · 2003
ScopolamineReactions Weekly · 2007
ScopolamineReactions Weekly · 2012
ScopolamineReactions Weekly · 2009
Centella asiaticaReactions Weekly · 2011
Daunorubicin/mitoxantroneReactions Weekly · 2007
AnthracyclinesReactions Weekly · 1991